Advaccine Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 191

Employees

  • Latest Deal Type
  • IPO

  • Investors
  • 15

Advaccine General Information

Description

Developer of viral vaccine technology intends to serve diabetes patients. The company currently has vaccines for hepatitis B, respiratory syncytial virus, type 1 diabetes and coronavirus in their research pipeline, enabling healthcare providers to deliver effective treatments to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 18 Qingqiu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • No. 18 Qingqiu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advaccine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. IPO 28-Feb-2023 Completed Generating Revenue
8. IPO 26-Oct-2021 Cancelled Generating Revenue
7. Later Stage VC (Series C) 26-Mar-2021 Completed Generating Revenue
6. Later Stage VC (Series B) 27-Nov-2020 Completed Generating Revenue
5. Later Stage VC 30-Sep-2020 Completed Generating Revenue
4. Later Stage VC 14-Sep-2020 Completed Generating Revenue
3. Later Stage VC 18-May-2020 Completed Generating Revenue
2. Later Stage VC 26-Feb-2020 $5.73M $8.63M Completed Generating Revenue
1. Later Stage VC 31-Mar-2017 $2.9M $2.9M Completed Generating Revenue
To view Advaccine’s complete valuation and funding history, request access »

Advaccine Patents

Advaccine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018229733-A1 Immuno-biomarkers distinguish responsiveness versus non-responsiveness during immunotherapeutic treatments Inactive 16-Jun-2017
CA-2937970-A1 Immunotherapeutic composition, method of treatment, and method of diagnosis Inactive 11-Feb-2014
AU-2015218098-A1 Immunotherapeutic composition, therapeutic method and diagnostic method Inactive 11-Feb-2014
AU-2018200638-A1 Immunotherapeutic composition, therapeutic method and diagnostic method Inactive 11-Feb-2014
EP-3106174-A1 Immunotherapeutic composition, therapeutic method and diagnostic method Inactive 11-Feb-2014 A61K38/20
To view Advaccine’s complete patent history, request access »

Advaccine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advaccine Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Goldstream Investment Corporation Minority
Hony Capital PE/Buyout Minority
Wosheng Investment Venture Capital Minority
Dunhong Capital Management PE/Buyout Minority
Red Horse Investment Group Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Advaccine FAQs

  • When was Advaccine founded?

    Advaccine was founded in 2009.

  • Where is Advaccine headquartered?

    Advaccine is headquartered in Suzhou, China.

  • What is the size of Advaccine?

    Advaccine has 191 total employees.

  • What industry is Advaccine in?

    Advaccine’s primary industry is Drug Discovery.

  • Is Advaccine a private or public company?

    Advaccine is a Private company.

  • What is Advaccine’s current revenue?

    The current revenue for Advaccine is .

  • How much funding has Advaccine raised over time?

    Advaccine has raised $166M.

  • Who are Advaccine’s investors?

    Goldstream Investment, Hony Capital, Wosheng Investment, Dunhong Capital Management, and Red Horse Investment Group are 5 of 15 investors who have invested in Advaccine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process